Similar articles

• Recent development of anti-cancer drugs for treatment of GI malignancies in Japan.

  Taguchi T. Taguchi T. Gan To Kagaku Ryoho. 2002 Feb;29 Suppl 1:76-80. Gan To Kagaku Ryoho. 2002. PMID: 11890118 No abstract available.
• A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.

  Morizane C. Morizane C. Jpn J Clin Oncol. 2007 Dec;37(12):973. doi: 10.1093/jjco/hym146. Jpn J Clin Oncol. 2007. PMID: 18211987 No abstract available.
• Treatment of metastatic pancreatic adenocarcinoma: a comprehensive review.

  Kozuch P, Petryk M, Evans A, Bruckner HW. Kozuch P, et al. Surg Clin North Am. 2001 Jun;81(3):683-90. doi: 10.1016/s0039-6109(05)70153-5. Surg Clin North Am. 2001. PMID: 11459281 Review.
• Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer.

  Takahara N, Nakai Y, Isayama H, Sasaki T, Satoh Y, Takai D, Hamada T, Uchino R, Mizuno S, Miyabayashi K, Mohri D, Kawakubo K, Kogure H, Yamamoto N, Sasahira N, Hirano K, Ijichi H, Tada M, Yatomi Y, Koike K. Takahara N, et al. Cancer Chemother Pharmacol. 2013 Jan;71(1):85-92. doi: 10.1007/s00280-012-1981-0. Epub 2012 Sep 29. Cancer Chemother Pharmacol. 2013. PMID: 23053265 Clinical Trial.
• [Non-surgical treatment for pancreatic cancer].

  Okusaka T, Ueno H, Ikeda M, Morizane C. Okusaka T, et al. Nihon Shokakibyo Gakkai Zasshi. 2006 Apr;103(4):391-7. Nihon Shokakibyo Gakkai Zasshi. 2006. PMID: 16629457 Review. Japanese. No abstract available.